このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Lincoln Pharmaceuticals バランスシートの健全性
財務の健全性 基準チェック /66
Lincoln Pharmaceuticalsの総株主資本は₹5.9B 、総負債は₹10.7Mで、負債比率は0.2%となります。総資産と総負債はそれぞれ₹7.0Bと₹1.1Bです。 Lincoln Pharmaceuticalsの EBIT は₹906.2Mで、利息カバレッジ比率60.9です。現金および短期投資は₹1.5Bです。
主要情報
0.2%
負債資本比率
₹10.67m
負債
| インタレスト・カバレッジ・レシオ | 60.9x |
| 現金 | ₹1.53b |
| エクイティ | ₹5.93b |
| 負債合計 | ₹1.07b |
| 総資産 | ₹7.00b |
財務の健全性に関する最新情報
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15
Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05Recent updates
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be Increased To ₹1.80
Sep 08Do Lincoln Pharmaceuticals' (NSE:LINCOLN) Earnings Warrant Your Attention?
Sep 06Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market
Mar 14Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Nov 04Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 14Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50
Aug 31Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 12Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50
Aug 29If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late
Feb 14Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?
Aug 16Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock
May 06Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?
Apr 03Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?
Feb 28Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares
Feb 12Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Feb 01
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years
Jan 19Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares
Jan 06Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar
Dec 27Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?
Dec 14Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?
Dec 01Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?
Nov 18Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05財務状況分析
短期負債: LINCOLNの 短期資産 ( ₹4.5B ) が 短期負債 ( ₹922.8M ) を超えています。
長期負債: LINCOLNの短期資産 ( ₹4.5B ) が 長期負債 ( ₹151.8M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: LINCOLN総負債よりも多くの現金を保有しています。
負債の削減: LINCOLNの負債対資本比率は、過去 5 年間で11.8%から0.2%に減少しました。
債務返済能力: LINCOLNの負債は 営業キャッシュフロー によって 十分にカバー されています ( 5925.9% )。
インタレストカバレッジ: LINCOLNの負債に対する 利息支払い は EBIT ( 60.9 x coverage) によって 十分にカバーされています。